Travoprost Ophthalmic Solution — Class II drug recall D-0867-2023
Terminated recall by Golden State Medical Supply Inc., reported 2023-06-14, distributed nationwide. Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
| Recall number | D-0867-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2023-05-25 |
| Classified | 2023-06-06 |
| Reported by FDA | 2023-06-14 |
| Terminated | 2025-08-08 |
| Distributed | Nationwide (US) |
| Quantity | 1,920 bottles |
| Reason classes | sterility, packaging |
| NDC | 51407-0731, 51407-0731-05, 51407-0731-25 |
| Expiration dates | 2024-03-31, 2024-09-30 |
Product
Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by: GSMS Incorporated, Camarillo, CA 93012, a) NDC 51407-731-25 (2.5 mL bottle), b) NDC 51407-731-05 (5 mL bottle).
Reason for recall
Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0867-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.